-transparent.png){kind=logo}
A pharmacokinetic method for individualizing theophylline dosage is described. The method was shown to be reliable and accurate, and maintained significantly more patients within the optimum therapeutic range when compared with conventional regimens. The study also showed that when conventional dosage regimens are used, a large proportion of patients exhibit theophylline levels well below the optimum therapeutic range. Population pharmacokinetic data for theophylline and the effect of congestive heart failure on its clearance are also presented.
Related Publications
R W Fitzpatrick, and
C Moss-Barclay
January 1983,
Therapeutic drug monitoring,
R W Fitzpatrick, and
C Moss-Barclay
January 1984,
European journal of respiratory diseases. Supplement,
R W Fitzpatrick, and
C Moss-Barclay
March 1981,
Srpski arhiv za celokupno lekarstvo,
R W Fitzpatrick, and
C Moss-Barclay
November 1992,
BMJ (Clinical research ed.),
R W Fitzpatrick, and
C Moss-Barclay
December 2006,
Therapeutic drug monitoring,
R W Fitzpatrick, and
C Moss-Barclay
April 1977,
American journal of hospital pharmacy,
R W Fitzpatrick, and
C Moss-Barclay
October 2005,
Computer methods and programs in biomedicine,
R W Fitzpatrick, and
C Moss-Barclay
April 1977,
American journal of hospital pharmacy,
R W Fitzpatrick, and
C Moss-Barclay
October 1997,
Managed care interface,
R W Fitzpatrick, and
C Moss-Barclay
December 1976,
Canadian journal of physiology and pharmacology,
